FY ended Dec 31, 2025 · figures in Philippine Peso except per-share rows
| Item | Current | Previous |
|---|---|---|
| Current assets | 2,378,853,515 | 2,331,001,575 |
| Total assets | 8,718,429,916 | 8,832,005,090 |
| Current liabilities | 2,015,962,430 | 1,852,196,619 |
| Total liabilities | 2,211,831,834 | 2,227,621,562 |
| Retained earnings/(deficit) | 1,673,239,095 | 2,097,287,335 |
| Stockholders' equity | 6,506,598,082 | 6,604,383,528 |
| Stockholders' equity (parent) | 5,807,033,301 | 5,890,081,541 |
| Book value per share | ₱3.07 | ₱3.11 |
| Item | Current | Previous |
|---|---|---|
| Gross revenue | 991,889,739(-12.3%) | 1,131,290,954 |
| Gross expense | 823,400,287 | 900,560,307 |
| Income/(loss) before tax | 25,386,355 | 38,691,290 |
| Net income/(loss) after tax | 6,274,277(-53.4%) | 13,455,970 |
| Net income/(loss), parent | 20,840,329 | 26,672,359 |
| EPS (basic) | ₱0.01 | ₱0.01 |
| EPS (diluted) | ₱0.01 | ₱0.01 |
SBS Philippines Corporation (SBS) was incorporated and registered with the Securities and Exchange Commission (SEC) on July 17, 2001 originally as Sytengco Philippines Corporation. On November 18, 2014, the SEC approved the Company's change in name to the present one. The core of SBS' operations is in the trading and warehouse distribution business as the Company generally procures chemicals by bulk and sells and distributes them to market customers in relatively smaller quantities. The Company sells chemicals that are used in manufacturing processes and as components of or ingredients in other products.
SBS offers a selection of chemical products to service the following industries: food ingredients, industrial, animal health and nutrition including feeds and veterinary care, pharmaceutical, home and personal care, environment and infrastructure, among others. The Company has warehouse facilities and distribution depots located in Quezon City, Malabon City, and Marilao, Bulacan. The Company also expanded its horizon for growth by making strategic investments in property-related assets and businesses.
As of December 31, 2024, the Company has one subsidiary, SBS Holdings and Enterprises Corporation.
TTM total
₱0.00
SBS Philippines Corporation trades on the Philippine Stock Exchange under the ticker symbol SBS.
SBS is listed in the Services sector of the Philippine Stock Exchange, where it ranks #26 of 62 by market capitalization. Across the whole exchange it is #135 of 282, at ₱5.6B.
Yes. SBS has paid 1 cash dividend in the last twelve months, totalling ₱0.00 per share. Cash dividends have a 10% final withholding tax deducted before they reach your account.
In its latest annual filing (fiscal year ended Dec 31, 2025), SBS's revenue fell 12.3% and net income fell 53.4% versus the prior fiscal year. That's one year-over-year comparison, not a multi-year trend, so check the Balance sheet & income statement panel above for the full figures before drawing a conclusion.
PSEye doesn't rate stocks as good or bad buys. What this page can tell you is factual: where SBS ranks by market cap (#135 of 282 on the exchange), its price history, valuation ratios, dividend record and recent company disclosures, all shown above. Whether that adds up to a good stock depends on your own criteria, and is worth researching beyond any single page, including this one.
PSEye is a data tracker, not a financial advisor, so it can't tell you whether to invest in SBS or any other stock. The price, valuation, dividend and disclosure data on this page is meant to help you do your own research. Consider your own goals, risk tolerance and time horizon, and consult a licensed financial advisor before making an investment decision. If you're weighing a fixed, regular investment instead of a single lump sum, PSEye's DCA calculator shows how that strategy would have performed historically.
To buy SBS shares, open an account with a PSE-accredited stockbroker (most Philippine banks and several standalone brokers offer online trading accounts), fund it, and place a buy order using the ticker symbol SBS. A completed trade typically settles two trading days later (T+2). PSEye doesn't process trades or recommend a specific broker.
Delayed/EOD data, not real-time. Figures are statistics on past closing prices, not a forecast.